MGFRF - MagForce AG

MagForce AG

Max-Planck-Strasse 3
Berlin 12489
Germany
49 30 308 380 0
https://www.magforce.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 33

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Benjamin J. Lipps	Chairman of the Management Board & CEO	N/A	N/A	1940
Mr. Christian Von Volkmann M.B.A., MBA	CFO & Member of Management Board	N/A	N/A	1971
Dr. Andreas Jordan	Exec. VP, Chief Scientific Officer & MD of Europe	N/A	N/A	1959
Ms. Barbara Von Frankenberg	VP of Communications & Investor Relations	N/A	N/A	N/A
Ms. Solveig Salomon	VP of Marketing & Sales and European Commercial Director	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment plan for the NanoTherm therapy; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.

Corporate governance

MagForce AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.